A citation-based method for searching scientific literature

Joonil Jung, Kexiang Xu, Derek Lessing, Nancy M Bonini. Hum Mol Genet 2009
Times Cited: 43



Ana T Simões, Nélio Gonçalves, Arnulf Koeppen, Nicole Déglon, Sebastian Kügler, Carlos Bandeira Duarte, Luís Pereira de Almeida. Brain 2012
Times Cited: 79




List of shared articles



Times cited


Cerebellar soluble mutant ataxin-3 level decreases during disease progression in Spinocerebellar Ataxia Type 3 mice.
Huu Phuc Nguyen, Jeannette Hübener, Jonasz Jeremiasz Weber, Stephan Grueninger, Olaf Riess, Andreas Weiss. PLoS One 2013
13


Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Jeannette Hübener, Jonasz Jeremiasz Weber, Claudia Richter, Lisa Honold, Andreas Weiss, Fabronia Murad, Peter Breuer, Ullrich Wüllner, Peter Bellstedt, Francois Paquet-Durand,[...]. Hum Mol Genet 2013
53

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
48

Polyglutamine spinocerebellar ataxias: emerging therapeutic targets.
Andreia Neves-Carvalho, Sara Duarte-Silva, Andreia Teixeira-Castro, Patrícia Maciel. Expert Opin Ther Targets 2020
3

Identification of the calpain-generated toxic fragment of ataxin-3 protein provides new avenues for therapy of Machado-Joseph disease| Spinocerebellar ataxia type 3.
Ana Teresa Simões, Vítor Carmona, Joana Duarte-Neves, Janete Cunha-Santos, Luís Pereira de Almeida. Neuropathol Appl Neurobiol 2021
0

Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Clévio Nóbrega, Ana Teresa Simões, Joana Duarte-Neves, Sónia Duarte, Ana Vasconcelos-Ferreira, Janete Cunha-Santos, Dina Pereira, Magda Santana, Cláudia Cavadas, Luís Pereira de Almeida. Adv Exp Med Biol 2018
9

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Jorge Diogo Da Silva, Andreia Teixeira-Castro, Patrícia Maciel. Neurotherapeutics 2019
16


Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.
Marina P Hommersom, Ronald A M Buijsen, Willeke M C van Roon-Mom, Bart P C van de Warrenburg, Hans van Bokhoven. Stem Cell Rev Rep 2021
0

From pathways to targets: understanding the mechanisms behind polyglutamine disease.
Jonasz Jeremiasz Weber, Anna Sergeevna Sowa, Tina Binder, Jeannette Hübener. Biomed Res Int 2014
34

A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3.
Jonasz J Weber, Matthias Golla, Giambattista Guaitoli, Pimthanya Wanichawan, Stefanie N Hayer, Stefan Hauser, Ann-Christin Krahl, Maike Nagel, Sebastian Samer, Eleonora Aronica,[...]. Brain 2017
21

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
12

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
38